Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia – A NOPHO ALL2008 study

Thromboembolism is a serious toxicity of acute lymphoblastic leukemia treatment, and contributes to substantial morbidity and mortality. Several single nucleotide polymorphisms have been associated with thromboembolism in the general population; however, their impact in patients with acute lymphoblastic leukemia, particularly in children, remains uncertain.

Source: Thrombosis Research - November 6, 2019 Category: Hematology Authors: Kirsten Brunsvig Jarvis, Marissa LeBlanc, Morten Tulstrup, Rikke Linnemann Nielsen, Birgitte Klug Albertsen, Ramneek Gupta, Pasi Huttunen, Olafur Gisli Jonsson, Cecilie Utke Rank, Susanna Ranta, Ellen Ruud, Kadri Saks, Sonata Saulyte Trakymiene, Ruta Tuck Tags: Full Length Article Source Type: research